Swedish Orphan Biovitrum AB (publ)

Common Name
Swedish Orphan Biovitrum
Country
Sweden
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,814
Ticker
SOBI
Exchange
NASDAQ STOCKHOLM AB
Description
Swedish Orphan Biovitrum AB is an international biopharmaceutical company specializing in the development, manufacturing, and marketing of innovative therapies for rare diseases. Its primary focus lie...

Swedish Orphan Biovitrum's GHG Emissions Data Preview

In 2024, Swedish Orphan Biovitrum completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Swedish Orphan Biovitrum has also provided a category-level breakdown for 9 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data

Verified Sources Behind Swedish Orphan Biovitrum’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Swedish Orphan Biovitrum’s data sources below and access millions more through our Disclosure Search.

a. Swedish Orphan Biovitrum's Annual Report 2024
a. Swedish Orphan Biovitrum's Annual Report 2024
b. Swedish Orphan Biovitrum's Annual Report 2022
b. Swedish Orphan Biovitrum's Annual Report 2022

Insights into Swedish Orphan Biovitrum's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Swedish Orphan Biovitrum amounted to 1,949 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Swedish Orphan Biovitrum increased by 1.04%, suggesting that the company faced challenges in reducing its emissions from its core operations. a

Swedish Orphan Biovitrum's Scope 1 Emissions Over Time

201820192020202120222023202403006009001.2 ktCO2e+20%+21%+4%+12%+34%+4%
  • Total Scope 1
  • Year-over-Year Change

What are Swedish Orphan Biovitrum's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Swedish Orphan Biovitrum were 1,097 metric tons of CO₂ equivalent (tCO₂e). a

Has Swedish Orphan Biovitrum reduced its Scope 1 emissions over time?

Since 2018, Swedish Orphan Biovitrum's Scope 1 emissions have increased by 134.9%, reflecting a rising long-term trend in Scope 1 emissions over time. a b

Compared to the previous year (2023), Swedish Orphan Biovitrum's Scope 1 emissions increased by 4.18%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a

What are Swedish Orphan Biovitrum's Scope 2 emissions?

In 2024, Swedish Orphan Biovitrum reported Scope 2 greenhouse gas (GHG) emissions of 771 tCO₂e using the market-based method and 852 tCO₂e using the location-based method. a

Has Swedish Orphan Biovitrum reduced its Scope 2 emissions over time?

Since 2018, Swedish Orphan Biovitrum's Scope 2 greenhouse gas (GHG) emissions ( Location-Based) have remained relatively stable, indicating that Swedish Orphan Biovitrum 's emissions have plateaued with no significant change in its energy consumption footprint. a b

Compared to the previous year (2023), Swedish Orphan Biovitrum's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Swedish Orphan Biovitrum 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does Swedish Orphan Biovitrum use for Scope 2 reporting?

In 2024, Swedish Orphan Biovitrum reported its Scope 2 emissions using the market-based method and using the location-based method. a

Swedish Orphan Biovitrum's Scope 2 Emissions Over Time

201820192020202120222023202405501.1 k1.65 k2.2 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Swedish Orphan Biovitrum's Value Chain Emissions

In 2024, Swedish Orphan Biovitrum reported 251,456 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a

The 2024 disclosure of Swedish Orphan Biovitrum includes a breakdown across 9 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year. a

Swedish Orphan Biovitrum's Scope 3 Emissions Over Time

202220232024065 k130 k195 k260 ktCO2e+71%+30%
  • Total Scope 3
  • Year-over-Year Change

What are Swedish Orphan Biovitrum's Scope 3 emissions?

In 2024, Swedish Orphan Biovitrum reported total Scope 3 emissions of 251,456 metric tons of CO₂ equivalent (tCO₂e). a

Approximately 99.99% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0.01% came from downstream activities like product use, distribution, and end-of-life treatment. a

Compared to the previous year (2023), Swedish Orphan Biovitrum's Scope 3 emissions increased by 30.21%, suggesting that the company faced challenges in reducing emissions across its value chain. a

What categories of Scope 3 emissions does Swedish Orphan Biovitrum disclose?

In 2024, Swedish Orphan Biovitrum reported emissions for 9 out of the 15 Scope 3 categories defined by the GHG Protocol. a

This partial disclosure allows for some insight into the company's indirect impacts.

What are the main sources of Swedish Orphan Biovitrum's Scope 3 emissions?

In 2024, the largest contributors to Swedish Orphan Biovitrum's Scope 3 emissions were: a

  • Purchased Goods and Services (Cat. 1): 216,133 tCO₂e (85.95%)
  • Capital Goods (Cat. 2): 18,007 tCO₂e (7.16%)
  • Business Travel (Cat. 6): 11,146 tCO₂e (4.43%)

Swedish Orphan Biovitrum's Scope 3 Emissions by Categories

Capital Goods(Cat. 2)(7.2%)Purchased Goods andServices (Cat. 1)(86.0%)Business Travel(Cat. 6)(4.4%)

Insights into Swedish Orphan Biovitrum’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Swedish Orphan Biovitrum reported Scope 1 greenhouse gas (GHG) emissions of 1,097 tCO₂e and total revenues of USD 2,362 millions. This translates into an emissions intensity of 0.46 tCO₂e per millions USD. a

Swedish Orphan Biovitrum's Scope 1 Emissions Intensity Compared to Peers

2002,00020,000100,0001,000,000Scope 1 Emissions (tCO2e)2001,0002,00010,00050,000Revenues (Millions of USD)CCCAlkermesYear: 2023Scope 1: 14,763 tCO2eRevenue: $M 1,663Scope 1 Intensity: 8.88 tCO2e/$MDivi's LaboratoriesYear: 2025Scope 1: 339,941 tCO2eRevenue: $M 1,091Scope 1 Intensity: 311.47 tCO2e/$MSimcere Pharmaceutical GroupYear: 2023Scope 1: 4,997 tCO2eRevenue: $M 1,017Scope 1 Intensity: 4.91 tCO2e/$MCCCR Double-CraneYear: 2023Scope 1: 51,608 tCO2eRevenue: $M 1,438Scope 1 Intensity: 35.88 tCO2e/$MAlmirallYear: 2023Scope 1: 6,318 tCO2eRevenue: $M 990Scope 1 Intensity: 6.38 tCO2e/$MHisamitsu PharmaceuticalYear: 2022Scope 1: 7,862 tCO2eRevenue: $M 1,040Scope 1 Intensity: 7.56 tCO2e/$MShionogi & CoYear: 2023Scope 1: 40,373 tCO2eRevenue: $M 3,203Scope 1 Intensity: 12.60 tCO2e/$MLivzon Pharmaceutical GroupYear: 2024Scope 1: 194,441 tCO2eRevenue: $M 1,619Scope 1 Intensity: 120.13 tCO2e/$MSawai Group HoldingsYear: 2023Scope 1: 19,500 tCO2eRevenue: $M 1,229Scope 1 Intensity: 15.87 tCO2e/$MCCChangchun High-TechYear: 2023Scope 1: 61,590 tCO2eRevenue: $M 2,050Scope 1 Intensity: 30.05 tCO2e/$MSiegfried HoldingYear: 2024Scope 1: 59,171 tCO2eRevenue: $M 1,430Scope 1 Intensity: 41.39 tCO2e/$MMankind PharmaYear: 2025Scope 1: 6,538 tCO2eRevenue: $M 1,429Scope 1 Intensity: 4.58 tCO2e/$MZydus LifesciencesYear: 2023Scope 1: 44,792 tCO2eRevenue: $M 2,056Scope 1 Intensity: 21.79 tCO2e/$MYuhanYear: 2024Scope 1: 7,059 tCO2eRevenue: $M 1,409Scope 1 Intensity: 5.01 tCO2e/$MGedeon RichterYear: 2024Scope 1: 45,632 tCO2eRevenue: $M 2,171Scope 1 Intensity: 21.02 tCO2e/$MGlenmark PharmaceuticalsYear: 2025Scope 1: 34,547 tCO2eRevenue: $M 1,539Scope 1 Intensity: 22.45 tCO2e/$MHanmi PharmYear: 2024Scope 1: 13,515 tCO2eRevenue: $M 1,019Scope 1 Intensity: 13.26 tCO2e/$MAlkem LaboratoriesYear: 2025Scope 1: 33,018 tCO2eRevenue: $M 1,499Scope 1 Intensity: 22.03 tCO2e/$MTeva Pharmaceutical IndustriesYear: 2024Scope 1: 243,603 tCO2eRevenue: $M 16,544Scope 1 Intensity: 14.72 tCO2e/$MIpsenYear: 2024Scope 1: 9,932 tCO2eRevenue: $M 3,720Scope 1 Intensity: 2.67 tCO2e/$MCCChina Resources SanjiuYear: 2024Scope 1: 55,312 tCO2eRevenue: $M 3,784Scope 1 Intensity: 14.62 tCO2e/$MDr Reddy's LaboratoriesYear: 2025Scope 1: 142,772 tCO2eRevenue: $M 3,810Scope 1 Intensity: 37.47 tCO2e/$MSwedish Orphan BiovitrumYear: 2024Scope 1: 1,097 tCO2eRevenue: $M 2,362Scope 1 Intensity: 0.46 tCO2e/$M

How does Swedish Orphan Biovitrum's GHG emissions intensity compare to its peers?

In 2024, Swedish Orphan Biovitrum reported a Scope 1 emissions intensity of 0.46 tCO₂e per millions USD. Compared to the peer group median of 15.3 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Swedish Orphan Biovitrum rank on GHG emissions intensity within its industry?

In 2024, Swedish Orphan Biovitrum ranked 1 out of 22 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places Swedish Orphan Biovitrum among the top performers, with one of the lowest emissions intensities relative to peers. a

Insights into Swedish Orphan Biovitrum's Total Carbon Footprint

In 2024, Swedish Orphan Biovitrum reported a total carbon footprint of 253,405 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 29.93% increase compared to 2023, suggesting a rise in emissions across its operations or value chain. a

The largest contributor to Swedish Orphan Biovitrum's total carbon footprint was Scope 3 emissions, accounting for 99.23% of the company's total carbon footprint, followed by Scope 1 emissions at 0.43%. a

Want Full Access to Swedish Orphan Biovitrum's GHG Emissions Dataset?
Sign Up